Fmr LLC Alnylam Pharmaceuticals, Inc. Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Fmr LLC holds 12,164,038 shares of ALNY stock, worth $3.22 Billion. This represents 0.19% of its overall portfolio holdings.

Number of Shares

12,164,038

Previous 9,967,996 22.03%

Holding current value

$3.22 Billion

Previous $1.49 Billion 98.42%

% of portfolio

0.19%

Previous 0.1%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$143.31 - $247.0 $315 Million - $542 Million	2,196,042 Added 22.03%	12,164,038 $2.96 Billion
Q1 2024 May 13, 2024	SELL	$146.51 - $198.2 $50.5 Million - $68.3 Million	-344,360 Reduced 3.34%	9,967,996 $1.49 Billion
Q4 2023 Feb 13, 2024	SELL	$151.41 - $196.57 $147 Million - $190 Million	-969,050 Reduced 8.59%	10,312,356 $1.97 Billion
Q3 2023 Nov 13, 2023	SELL	$170.77 - $211.65 $207 Million - $256 Million	-1,211,094 Reduced 9.69%	11,281,406 $2 Billion
Q2 2023 Aug 11, 2023	SELL	$185.01 - $212.05 $125 Million - $144 Million	-678,335 Reduced 5.15%	12,492,500 $2.37 Billion
Q1 2023 May 11, 2023	SELL	$182.66 - $235.53 $62.3 Million - $80.4 Million	-341,248 Reduced 2.53%	13,170,835 $2.64 Billion
Q4 2022 Feb 13, 2023	BUY	$185.53 - $241.31 $104 Million - $136 Million	562,325 Added 4.34%	13,512,083 $3.21 Billion
Q3 2022 Nov 10, 2022	SELL	$138.54 - $232.0 $190 Million - $319 Million	-1,374,991 Reduced 9.6%	12,949,758 $2.59 Billion
Q2 2022 Aug 12, 2022	SELL	$120.42 - $169.29 $207 Million - $291 Million	-1,720,567 Reduced 10.72%	14,324,749 $2.09 Billion
Q1 2022 May 13, 2022	SELL	$127.18 - $173.91 $241 Million - $330 Million	-1,894,704 Reduced 10.56%	16,045,316 $2.62 Billion
Q4 2021 Feb 14, 2022	BUY	$159.56 - $209.29 $18 Million - $23.7 Million	113,092 Added 0.63%	17,940,020 $3.04 Billion
Q3 2021 Nov 15, 2021	BUY	$169.75 - $207.73 $33.1 Million - $40.5 Million	195,199 Added 1.11%	17,826,928 $3.37 Billion
Q2 2021 Aug 13, 2021	BUY	$128.63 - $176.89 $2.27 Billion - $3.12 Billion	17,631,729 New	17,631,729 $2.99 Billion

Others Institutions Holding ALNY

# of Institutions

614

Shares Held

108M

Call Options Held

2.33M

Put Options Held

2.17M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $32.6B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account